Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up.
Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up.
Sponsor study identifier
interventional
200
1 country
4
Study Start
December 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
August 2011
Actual (reported)The majority of lung cancer patients have a tumor-derived genetic alteration in circulating plasma DNA that could be exploited as a diagnostic tool. The aim of this study is to evaluate if plasma DNA can be used as a valuable non invasive test to monitor disease progression without assessing the tumor.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2011
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2003
Date type not reportedThis date has not been verified as actual or estimated.
September 13, 2005
Actual (reported)September 21, 2005
Actual (reported)August 2011
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Service de Pneumologie, Hôpital Lyautey
Strasbourg, 67000, France
Service de Chirurgie Thoracique, Hôpital Civil
Strasbourg, 67091, France
Service de Pneumologie, Hôpital Civil
Strasbourg, 67091, France
Service de Pneumologie, Hôpital de Hautepierre
Strasbourg, 67098, France
Beau-Faller M, Gaub MP, Schneider A, Ducrocq X, Massard G, Gasser B, Chenard MP, Kessler R, Anker P, Stroun M, Weitzenblum E, Pauli G, Wihlm JM, Quoix E, Oudet P. Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients. Int J Cancer. 2003 Jun 20;105(3):361-70. doi: 10.1002/ijc.11079.
Michèle BEAU-FALLER, MD
Service de Pneumologie, Hôpital de Hautepierre
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
December 2003
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
August 2011
Actual (reported)Contact the study team to confirm eligibility.
Last Updated
December 22, 2025
Record last verified: 2025-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: